Newly Acquired Infection With Multidrug-Resistant HIV-1 in a Patient Adherent to Preexposure Prophylaxis

被引：53
|
作者：
Markowitz, Martin [1 ]
Grossman, Howard [2 ]
Anderson, Peter L. [3 ]
Grant, Robert [4 ]
Gandhi, Monica [4 ]
Horng, Howard [4 ]
Mohri, Hiroshi [1 ]
机构：
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA
[2] Cleveland Clin Florida, Weston, FL 33331 USA
[3] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
[4] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2017年 / 76卷 / 04期
关键词：
ANTIRETROVIRAL THERAPY; TRANSMISSION; RISK; MEN;
D O I：
10.1097/QAI.0000000000001534
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E104 / E106
页数：3
相关论文
共 50 条
  • [31] A multidrug-resistant (MDR) HIV type 1 infection in a homosexual man and identified source patient
    Monno, Laura
    Punzi, Grazia
    Brindicci, Gaetano
    Lagioia, Antonella
    Ladisa, Nicoletta
    Saracino, Annalisa
    Ingletti, Maria
    Angarano, Gioacchino
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (10) : 1293 - 1295
  • [32] The demise of multidrug-resistant HIV-1: the national time trend in Portugal
    Vercauteren, Jurgen
    Theys, Kristof
    Carvalho, Ana Patricia
    Valadas, Emilia
    Duque, Luis Miguel
    Teofilo, Eugenio
    Faria, Telo
    Faria, Domitilia
    Vera, Jose
    Aguas, Maria Joao
    Peres, Susana
    Mansinho, Kamal
    Vandamme, Anne-Mieke
    Camacho, Ricardo Jorge
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (04) : 911 - 914
  • [33] Multidrug-resistant, dual-tropic HIV-1 and rapid progression
    Jefferys, R
    LANCET, 2005, 365 (9475): : 1923 - 1923
  • [34] Design of HIV-1 protease inhibitors active on multidrug-resistant virus
    Surleraux, DLNG
    de Kock, HA
    Verschueren, WG
    Pille, GME
    Maes, LJR
    Peeters, A
    Vendeville, S
    De Meyer, S
    Azijn, H
    Pauwels, R
    de Bethune, MP
    King, NM
    Prabu-Jeyabalan, M
    Schiffer, CA
    Wigerinck, PBTP
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 1965 - 1973
  • [35] What is the risk of mortality following diagnosis of multidrug-resistant HIV-1?
    Grover, D.
    Copas, A.
    Green, H.
    Edwards, S. G.
    Dunn, D. T.
    Sabin, C.
    Phillips, A.
    Allen, E.
    Pillay, D.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 705 - 713
  • [36] Sexual transmission of HIV-1: Preexposure and postexposure prophylaxis
    Nielsen, K
    INFECTIONS IN MEDICINE, 2005, 22 (04) : 175 - +
  • [37] LONG-TERM HEALTH BENEFIT OF IBALIZUMAB IN THE TREATMENT OF ADULTS WITH MULTIDRUG-RESISTANT HIV-1 INFECTION
    Brogan, A. J.
    Talbird, S. E.
    Davis, A. E.
    La, E. M.
    Miao, Z.
    Lewis, S.
    VALUE IN HEALTH, 2018, 21 : S12 - S12
  • [38] HIV-1 genetic diversity to estimate time of infection and infer adherence to preexposure prophylaxis
    Council, Olivia D.
    Ruone, Susan
    Mock, Philip A.
    Khalil, George
    Martin, Amy
    Curlin, Marcel E.
    Mcnicholl, Janet M.
    Heneine, Walid
    Leelawiwat, Wanna
    Choopanya, Kachit
    Vanichseni, Suphak
    Cherdtrakulkiat, Thitima
    Anekvorapong, Rapeepan
    Martin, Michael
    Garcia-Lerma, J. Gerardo
    AIDS, 2019, 33 (15) : 2299 - 2307
  • [39] Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus
    Lee, Natalie E. E.
    Sutherland, Rebecca K. K.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2023, 36 (01) : 15 - 19
  • [40] HIV infection and multidrug-resistant tuberculosis - The perfect storm
    Wells, Charles D.
    Cegielski, J. Peter
    Nelson, Lisa J.
    Laserson, Kayla F.
    Holtz, Timothy H.
    Finlay, Alyssa
    Castro, Kenneth G.
    Weyer, Karin
    JOURNAL OF INFECTIOUS DISEASES, 2007, 196 : S86 - S107
12345